CEO Insights team
I am thrilled to join MCRA's team and build upon its reputation for providing expert reimbursement and market access guidance in the medical device space
Excited on her new role, Tonya comments, “I am thrilled to join MCRA's team and build upon its reputation for providing expert reimbursement and market access guidance in the medical device space. I look forward to building a best in class reimbursement department and broadening its scope, to ensure this key component is factored into our clients' commercialization strategy both early and throughout the product life cycle. MCRA's integrated service model has a history of success,
and this coordinated approach will become increasingly important as companies have even greater requirements to generate and efficiently provide evidence to multiple stakeholders”.
With a comprehensive understanding of the US healthcare delivery and payment systems, healthcare reform, public and private payer reimbursement mechanism and more, Tonya focused her career on developing and executing systematic strategies that integrate health economics, outcomes research across all stages of the technology cycle. Prior to MCRA, Tonya was the Global Director at Johnson & Johnson, and the mastermind behind the product planning with the R&D, global strategic marketing, clinical and global regional teams to ensure a competitive advantage and market access of products. Tonya with a rich experience of 25 years in reimbursement and market access experience has dealt with healthcare companies such as Acclarent, Affymetrix, Allergan, Biosense Webster, Cerenovus, Codman, Enteromedics, Ethicon Endo-Surgery, Glaukos and more. She also holds a BA in Health Policy from the University of Michigan and a Masters in Public Health from the University of California Los Angeles.
David Lown, President, MCRA, says, “Reimbursement for medical technology has never been more complex and multifaceted throughout the entire continuum; beginning with an invention and ending with the entire patient episode of care. Today's integrated clinical, regulatory and reimbursement challenges present significant obstacles to the entrepreneurs and companies who look to improve patient care either incrementally or exponentially. With the hiring of Tonya, I am very confident MCRA is taking a leadership position in assisting the industry, and ultimately, all stakeholders on these challenges."
With a comprehensive understanding of the US healthcare delivery and payment systems, healthcare reform, public and private payer reimbursement mechanism and more, Tonya focused her career on developing and executing systematic strategies that integrate health economics, outcomes research across all stages of the technology cycle. Prior to MCRA, Tonya was the Global Director at Johnson & Johnson, and the mastermind behind the product planning with the R&D, global strategic marketing, clinical and global regional teams to ensure a competitive advantage and market access of products. Tonya with a rich experience of 25 years in reimbursement and market access experience has dealt with healthcare companies such as Acclarent, Affymetrix, Allergan, Biosense Webster, Cerenovus, Codman, Enteromedics, Ethicon Endo-Surgery, Glaukos and more. She also holds a BA in Health Policy from the University of Michigan and a Masters in Public Health from the University of California Los Angeles.
David Lown, President, MCRA, says, “Reimbursement for medical technology has never been more complex and multifaceted throughout the entire continuum; beginning with an invention and ending with the entire patient episode of care. Today's integrated clinical, regulatory and reimbursement challenges present significant obstacles to the entrepreneurs and companies who look to improve patient care either incrementally or exponentially. With the hiring of Tonya, I am very confident MCRA is taking a leadership position in assisting the industry, and ultimately, all stakeholders on these challenges."